Selank has an IV half-life of just 46 minutes, making it one of the shortest-lived peptides on this peptide half-life chart
Common, usually mild: Injection-site reactions (redness, swelling, itching), most frequent with both Mild headache, dizziness, or flushing after injection Initial water retention as IGF-1 rises Transient fatigue in the first 12 weeks Less common, dose-dependent: Carpal tunnel-like wrist symptoms (sign IGF-1 may be too high) Joint discomfort or stiffness Numbness or tingling in extremities Elevated blood glucose (GH antagonizes insulin) The monitoring that matters:IGF-1 (insulin-like growth factor 1, the downstream marker of GH activity) is the lab value that tells you whether youre in a therapeutic range or pushing past it
Nevertheless, researchers may consider administering the peptide twice daily instead of once daily, considering the short half-life after an infusion
Bronchogen Peptide Vial The Bronchogen Peptide Vial is a synthetic, lyophilized research peptide supplied at 98% purity in a sterile glass vial, formulated for advanced laboratory investigation into respiratory and pulmonary biology
M., Payette, H., & Wagner, J
